Huang Alan 4
4 · Tango Therapeutics, Inc. · Filed Feb 3, 2022
Insider Transaction Report
Form 4
Huang Alan
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-01+200,000→ 200,000 totalExercise: $9.22Exp: 2032-02-01→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2023, with the remaining option shares vesting in 36 equal monthly installments thereafter.